Nuvation Bio (NUVB) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $68.1 million.
- Nuvation Bio's Total Current Liabilities rose 1540.78% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.1 million, marking a year-over-year increase of 1540.78%. This contributed to the annual value of $58.2 million for FY2024, which is 31680.26% up from last year.
- As of Q3 2025, Nuvation Bio's Total Current Liabilities stood at $68.1 million, which was up 1540.78% from $66.4 million recorded in Q2 2025.
- Nuvation Bio's 5-year Total Current Liabilities high stood at $68.1 million for Q3 2025, and its period low was $12.6 million during Q1 2023.
- Over the past 3 years, Nuvation Bio's median Total Current Liabilities value was $51.1 million (recorded in 2024), while the average stood at $38.9 million.
- As far as peak fluctuations go, Nuvation Bio's Total Current Liabilities surged by 31680.26% in 2024, and later surged by 1540.78% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Total Current Liabilities stood at $14.0 million in 2023, then soared by 316.8% to $58.2 million in 2024, then rose by 16.98% to $68.1 million in 2025.
- Its Total Current Liabilities stands at $68.1 million for Q3 2025, versus $66.4 million for Q2 2025 and $52.8 million for Q1 2025.